P 3 Therapeutics Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$292K
- Investors
-
2
P 3 Therapeutics General Information
Description
Developer of small chemical molecules designed to target anti-inflammatory pathways involved in chronic inflammation and immune-mediated diseases. The company's preclinical drug candidates target pathways associated with intestinal permeability, spondyloarthritis, inflammatory bowel disease, and related conditions, enabling the development of potential treatments for chronic inflammatory diseases.
Contact Information
Website
www.p3therapeutics.euCorporate Office
- Biocentar
- Borongajska 83H
- Zagreb, Zagreb 10000
- Croatia
Corporate Office
- Biocentar
- Borongajska 83H
- Zagreb, Zagreb 10000
- Croatia
P 3 Therapeutics Timeline
P 3 Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 01-Jun-2026 | $292K | Completed | Pre-Clinical Trials | ||
| 1. Seed Round | 01-Apr-2025 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
P 3 Therapeutics Comparisons
Industry
Financing
Details
P 3 Therapeutics Competitors (4)
One of P 3 Therapeutics’s 4 competitors is AbbVie, a Corporation company based in North Chicago, IL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AbbVie | Corporation | North Chicago, IL | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| GSK | Corporation | London, United Kingdom | ||||
| Pfizer (Distributors/Wholesale) | Corporation | Oslo, Norway |
P 3 Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
P 3 Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
P 3 Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| SEE UP Accelerator | Accelerator/Incubator | Minority | ||
| Vesna Deep Tech Fund | Venture Capital | Minority |
P 3 Therapeutics FAQs
-
When was P 3 Therapeutics founded?
P 3 Therapeutics was founded in 2024.
-
Where is P 3 Therapeutics headquartered?
P 3 Therapeutics is headquartered in Zagreb, Croatia.
-
What is the size of P 3 Therapeutics?
P 3 Therapeutics has 2 total employees.
-
What industry is P 3 Therapeutics in?
P 3 Therapeutics’s primary industry is Drug Discovery.
-
Is P 3 Therapeutics a private or public company?
P 3 Therapeutics is a Private company.
-
What is the current valuation of P 3 Therapeutics?
The current valuation of P 3 Therapeutics is .
-
What is P 3 Therapeutics’s current revenue?
The current revenue for P 3 Therapeutics is .
-
How much funding has P 3 Therapeutics raised over time?
P 3 Therapeutics has raised $400K.
-
Who are P 3 Therapeutics’s investors?
SEE UP Accelerator and Vesna Deep Tech Fund have invested in P 3 Therapeutics.
-
Who are P 3 Therapeutics’s competitors?
AbbVie, Novartis, GSK, and Pfizer (Distributors/Wholesale) are competitors of P 3 Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
